Big pharma more open to strong relationships, less heavy handed

By Nick Taylor & Claire Videau

- Last updated on GMT

Big pharma has taken a less heavy handed approach to relationships as cutbacks have made outsourcing key, according to Stephen Munk, CEO of Ash Stevens.

In the past Ash Stevens was competing with in-house big pharma capacity, said Munk, but the need to trim operations has shifted the environment. This has been accompanied by a change in attitude, with big pharma becoming less heavy handed and more open to strong relationships.

Typically Ash Stevens will establish a prime contact who acts as “a weaver of the entire fabric of the process​”. This ensures one point of contact understands all elements of the project, from engineering requirements to regulatory affairs.

Related topics: Contract Manufacturing, Bulk ingredients

Related news

Show more

Related suppliers